Your browser doesn't support javascript.
loading
The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond.
Russell, Nancy; Jennings, Susan; Jennings, Blair; Slee, Valerie; Sterling, Lisa; Castells, Mariana; Valent, Peter; Akin, Cem.
Affiliation
  • Russell N; The Mastocytosis Society, Inc., Sterling, Mass.
  • Jennings S; The Mastocytosis Society, Inc., Sterling, Mass.
  • Jennings B; The Mastocytosis Society, Inc., Sterling, Mass.
  • Slee V; The Mastocytosis Society, Inc., Sterling, Mass.
  • Sterling L; The Mastocytosis Society, Inc., Sterling, Mass.
  • Castells M; Mastocytosis Center, Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
  • Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Akin C; Department of Internal Medicine, Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Mich. Electronic address: cemakin@med.umich.edu.
J Allergy Clin Immunol Pract ; 7(4): 1157-1165.e6, 2019 04.
Article in En | MEDLINE | ID: mdl-30098409
ABSTRACT

BACKGROUND:

Mast cell diseases such as mastocytosis and mast cell activation syndrome involve abnormal proliferation and/or activation of these cells, leading to many clinically relevant symptoms.

OBJECTIVE:

To determine the characteristics and experiences of people known or suspected to have a mast cell disorder, The Mastocytosis Society, a US-based patient advocacy, research, and education organization, conducted a survey of patients.

METHODS:

This Web-based survey was publicized through specialty clinics and the society's newsletter, Web site, and online blogs. Both online and paper copies of the questionnaire were provided together with required statements of consent.

RESULTS:

The first set of results from this survey of 420 respondents has been previously published; the second set is presented in this article. These results include source(s) of diagnosis, clinical and laboratory tests reported, comorbidities, dietary practices, possible familial occurrence of mast cell disorders, and perceptions concerning mast cell disorder-related medical care needs in the United States.

CONCLUSIONS:

These patient survey results are provided to assist medical professionals in learning patients' perceptions of their experiences and to give patients with mast cell disorders and caregivers the opportunity to compare experiences with those of other affected individuals.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 2_ODS3 Database: MEDLINE Main subject: Family / Mastocytosis, Cutaneous / Mastocytosis, Systemic / Diet Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 Country/Region as subject: America do norte Language: En Journal: J Allergy Clin Immunol Pract Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 2_ODS3 Database: MEDLINE Main subject: Family / Mastocytosis, Cutaneous / Mastocytosis, Systemic / Diet Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged80 Country/Region as subject: America do norte Language: En Journal: J Allergy Clin Immunol Pract Year: 2019 Document type: Article